Reducing obesity via GLP-1 drugs could create healthier workforces, spike productivity, reduce absenteeism, and impact GDPs, Capital Economics said.
Original Image Link
Source:www.businessinsider.com
Original Image Link
Source:www.businessinsider.com
Posted: 2024-03-15 05:09:00